BioPharm International is committed...

BioPharm International is committed to bringing you the mostly valuable industry news, no matter where in the world it happens. in like manner the excitement level at our Iselin, NJ headquarters was high last January when we learned we'd be able to propound you the inside story of the exhibition and manufacture of Gendicine, the first licensed gene-based therapeutic for head and neck squamous small room cancer.

With the help of of recent origin Brunswick Scientific's Suzy Kedzierski, BioPharm arranged to mode of action what turned out to be the first in-depth interview according to anyone outside of China with Dr Zhaohui Peng